close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

105.66 +0.91 (+0.87%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 361,160
Open 105.84
Bid (Size) 104.90 (1)
Ask (Size) 106.42 (1)
Prev. Close 104.75
Today's Range 104.52 - 106.64
52wk Range 81.20 - 129.27
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Unstoppable Dividend Stocks Yielding More Than 4% That Income-Seeking Investors Will Want to Buy in November and Hold Forever
Both companies are monsters in their industry and are poised to thrive. 
Via The Motley Fool
Topics Government Intellectual Property World Trade
BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.
From BioNTech SE
Via GlobeNewswire

Performance

YTD
-8.4%
-8.4%
1 Month
+5.9%
+5.9%
3 Month
-8.4%
-8.4%
6 Month
+3.6%
+3.6%
1 Year
-5.4%
-5.4%

More News

Read More
Beyond The Numbers: 7 Analysts Discuss BioNTech Stock
Via Benzinga
Ionis Pharmaceuticals (NASDAQ:IONS) Ascends to Six-Year High, Fueled by Breakthrough Pipeline and Robust Sales Outlook
Via MarketMinute
Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead
Via The Motley Fool
Topics Government World Trade
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures
Via MarketMinute
Topics Artificial Intelligence Derivatives
Pfizer, BioNTech’s Updated COVID-19 Vaccine Shows Robust Immune Response In Late-Stage Study – More Details Inside
Via Stocktwits
Why BioNTech Stock Jumped by Nearly 4% on Wednesday
Via The Motley Fool
Topics Artificial Intelligence Government World Trade
BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025
From BioNTech SE
Via GlobeNewswire
Why BioNTech Stock Bumped Higher Today
Via The Motley Fool
What Analysts Are Saying About BioNTech Stock
Via Benzinga
CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids
Via Investor's Business Daily
The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut
Via Investor's Business Daily
Topics Government
Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
Via FinancialNewsMedia
Topics Artificial Intelligence
Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax
Via Benzinga
Oracle Retreats, Fed Rate Cut Looms, and Vaccine Politics Shake Pharma Stocks
Via Chartmill
Topics Artificial Intelligence Economy
Synopsys, Chewy, And The Trade Desk Are Among Top 10 Large Cap Losers Last Week (Sep. 8- Sep. 12): Are The Others In Your Portfolio?
Via Benzinga
Topics Earnings
Why BioNTech Stock Sank by More Than 7% Today
Via The Motley Fool
Topics Death Government
Pfizer, Moderna, BioNTech Stocks Tumble After Report Of Plan To Link COVID Vaccines To Child Deaths
Via Benzinga
Topics Government
China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order
Via Investor's Business Daily
Topics Government
Pfizer, BioNTech Roll Out COVID-19 Update That Boosts Antibodies 4-Fold In High-Risk Adults
Via Benzinga
BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy
Via Benzinga
First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity
From BioNTech SE
Via GlobeNewswire
Summit Therapeutics Crashes After Failing To Deliver Another Merck-Walloping Punch
Via Investor's Business Daily

Frequently Asked Questions

Is BioNTech SE - American Depositary Shares publicly traded?
Yes, BioNTech SE - American Depositary Shares is publicly traded.
What exchange does BioNTech SE - American Depositary Shares trade on?
BioNTech SE - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for BioNTech SE - American Depositary Shares?
The ticker symbol for BioNTech SE - American Depositary Shares is BNTX on the Nasdaq Stock Market
What is the current price of BioNTech SE - American Depositary Shares?
The current price of BioNTech SE - American Depositary Shares is 105.66
When was BioNTech SE - American Depositary Shares last traded?
The last trade of BioNTech SE - American Depositary Shares was at 10/24/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today